Angebote zu "Upper" (20 Treffer)

Kategorien

Shops

Helicobacter Pylori Infection and Upper Gastro-...
45,90 € *
ggf. zzgl. Versand

There are controversies regarding relationship between Helicobacter pylori (H. pylori) and upper gastro-intestinal bleeding (UGIB )in children. The goal of this study was to assess the relationship between H. pylori infection and UGIB in Northern Iranian children. One hundred children who had UGIB indicated for upper gastrointestinal endoscopy and 100 children without UGIB who were candidate for upper endoscopy because of chronic abdominal pain considered as their controls. After stabling vital sign, nasogastric tube inserted and washing was done then within 24 hours of admission, endoscopy conducted for all children in the case group (under general anesthesia). Upper endoscopy was done for all participants by a children gastroenterologist. A single pathologist reviewed all specimens. Mean age of cases was 6.2±3.2 years and mean age of controls was 7.1±2.9 years respectively. There was no relationship between H. pylori and UGIB. Erosion in fondus was significantly higher in cases (0.001) and erythema in antrum was significantly higher in controls (p0.001).

Anbieter: Dodax
Stand: 19.01.2020
Zum Angebot
Management of Helicobacter pylori infection
50,40 € *
ggf. zzgl. Versand

Prevalence of Helicobacter pylori (H. pylori) is very high and well documented in gastroenterological disorders like gastritis, gastric carcinoma, peptic ulcer disease, non ulcer dyspepsia and gastroesophageal reflux disease. More than 50% of the world's population harbor Helicobacter pylori in their upper gastrointestinal tract. It causes a chronic low-level inflammation of the stomach lining and is strongly linked to the development of duodenal and gastric ulcers and stomach cancer. This book will provide the readers a better understanding about the H. pylori related gastroenterological disorders and their proper management with clinical comparative research oriented herbal medicines.

Anbieter: Dodax AT
Stand: 19.01.2020
Zum Angebot
Management of Helicobacter pylori infection
49,00 € *
ggf. zzgl. Versand

Prevalence of Helicobacter pylori (H. pylori) is very high and well documented in gastroenterological disorders like gastritis, gastric carcinoma, peptic ulcer disease, non ulcer dyspepsia and gastroesophageal reflux disease. More than 50% of the world's population harbor Helicobacter pylori in their upper gastrointestinal tract. It causes a chronic low-level inflammation of the stomach lining and is strongly linked to the development of duodenal and gastric ulcers and stomach cancer. This book will provide the readers a better understanding about the H. pylori related gastroenterological disorders and their proper management with clinical comparative research oriented herbal medicines.

Anbieter: Dodax
Stand: 19.01.2020
Zum Angebot
Gastric & oesophageal adenocarcinoma
97,60 € *
ggf. zzgl. Versand

One in every eight cancers in the world develops in the oesophagus or stomach. While the incidence of gastric adenocarcinoma and oesophageal squamous cell carcinoma have declined in recent decades, oesophageal adenocarcinoma has increased more than any other cancer. Infection with Helicobacter pylori, dietary salt and smoking are the main risk factors for gastric and oesophageal cancer. Gastro-oesophageal reflux disease (GORD), Barrett s oesophagus and obesity are risk factors for oesophageal adenocarcinoma. Adenocarcinomas of the oesophago-gastric junction and cardia include two distinct types, one resembling gastric cancer caused by H.pylori infection, the other, associated with GORD, resembling Barrett s adenocarcinoma. Gender is also a major intrinsic factor, with upper gastrointestinal cancer much commoner in men. The current work examines this male predominance at the population level and with reference to Lauren histological type, showing that only intestinal-type but not diffuse type upper GI cancers occur more frequently in men.

Anbieter: Dodax AT
Stand: 19.01.2020
Zum Angebot
Gastric & oesophageal adenocarcinoma
94,90 € *
ggf. zzgl. Versand

One in every eight cancers in the world develops in the oesophagus or stomach. While the incidence of gastric adenocarcinoma and oesophageal squamous cell carcinoma have declined in recent decades, oesophageal adenocarcinoma has increased more than any other cancer. Infection with Helicobacter pylori, dietary salt and smoking are the main risk factors for gastric and oesophageal cancer. Gastro-oesophageal reflux disease (GORD), Barrett s oesophagus and obesity are risk factors for oesophageal adenocarcinoma. Adenocarcinomas of the oesophago-gastric junction and cardia include two distinct types, one resembling gastric cancer caused by H.pylori infection, the other, associated with GORD, resembling Barrett s adenocarcinoma. Gender is also a major intrinsic factor, with upper gastrointestinal cancer much commoner in men. The current work examines this male predominance at the population level and with reference to Lauren histological type, showing that only intestinal-type but not diffuse type upper GI cancers occur more frequently in men.

Anbieter: Dodax
Stand: 19.01.2020
Zum Angebot
Proton Pump Inhibitors: A Balanced View
171,54 € *
ggf. zzgl. Versand

The discovery of proton pump inhibitors (PPIs) and their development over the years has dramatically changed the management of acid-related diseases. Today, the therapeutic domain of PPIs ranges from relief of symptoms to cure of mucosal lesions in the upper gastrointestinal tract. PPIs are among the most widely sold drugs in the world and are now even available as over-the-counter medication. This publication presents the experience of the last 25 years during which PPIs have become of enormous value in gastroenterology. The authors provide an update on a variety of subjects, starting with an introduction to the discovery and development of PPIs. This is followed by chapters on pharmacokinetics, pharmacodynamics and pharmacogenetics, gastroesophageal reflux disease, gastroprotection, Helicobacter pylori eradication treatment, peptic ulcer disease, functional dyspepsia, acid suppression in exocrine pancreatic insufficiency, and gastrointestinal and systemic side effects. Readers who are interested in a current overview of PPIs and their various applications will find this book of great value.

Anbieter: Dodax
Stand: 19.01.2020
Zum Angebot
Proton Pump Inhibitors: A Balanced View
172,75 € *
ggf. zzgl. Versand

The discovery of proton pump inhibitors (PPIs) and their development over the years has dramatically changed the management of acid-related diseases. Today, the therapeutic domain of PPIs ranges from relief of symptoms to cure of mucosal lesions in the upper gastrointestinal tract. PPIs are among the most widely sold drugs in the world and are now even available as over-the-counter medication. This publication presents the experience of the last 25 years during which PPIs have become of enormous value in gastroenterology. The authors provide an update on a variety of subjects, starting with an introduction to the discovery and development of PPIs. This is followed by chapters on pharmacokinetics, pharmacodynamics and pharmacogenetics, gastroesophageal reflux disease, gastroprotection, Helicobacter pylori eradication treatment, peptic ulcer disease, functional dyspepsia, acid suppression in exocrine pancreatic insufficiency, and gastrointestinal and systemic side effects. Readers who are interested in a current overview of PPIs and their various applications will find this book of great value.

Anbieter: Dodax AT
Stand: 19.01.2020
Zum Angebot
Multiparticulate System For Peptic Ulcer
60,70 € *
ggf. zzgl. Versand

The discovery of Helicobacter pylori as the cause of peptic ulcer has revolutionized anti-ulcer treatment. The current treatment includes a combination of antibiotics with proton pump inhibitors or H2 receptor antagonist1,2. Clarithromycin and omeprazole combination has become popular and best choice for treating peptic ulcer associated with H. pylori infection3. Gastro retentive dosage forms have the potential for increased residence in stomach along with site-specific drug delivery. Hydrodynamic drug delivery systems (HBS) are one such systems that has increased gastric residence providing an increased local action at the ulcer site4. Clarithromycin, effective in H.pylori infection treatment was chosen as model drug. Extended release and retention in upper gastro intestinal tract would be most advantageous, optimizing the combination therapy of peptic ulcer complicated with H.pylori. Omeprazole was formulated as fast dissolving enteric-coated pellets by using extrusion spheronisation technique. Enteric coating material used was Eudragit 30D-L-55.

Anbieter: Dodax AT
Stand: 19.01.2020
Zum Angebot
Multiparticulate System For Peptic Ulcer
59,00 € *
ggf. zzgl. Versand

The discovery of Helicobacter pylori as the cause of peptic ulcer has revolutionized anti-ulcer treatment. The current treatment includes a combination of antibiotics with proton pump inhibitors or H2 receptor antagonist1,2. Clarithromycin and omeprazole combination has become popular and best choice for treating peptic ulcer associated with H. pylori infection3. Gastro retentive dosage forms have the potential for increased residence in stomach along with site-specific drug delivery. Hydrodynamic drug delivery systems (HBS) are one such systems that has increased gastric residence providing an increased local action at the ulcer site4. Clarithromycin, effective in H.pylori infection treatment was chosen as model drug. Extended release and retention in upper gastro intestinal tract would be most advantageous, optimizing the combination therapy of peptic ulcer complicated with H.pylori. Omeprazole was formulated as fast dissolving enteric-coated pellets by using extrusion spheronisation technique. Enteric coating material used was Eudragit 30D-L-55.

Anbieter: Dodax
Stand: 19.01.2020
Zum Angebot